Skip to main content
Log in

Juvenile systemic lupus erythematosus: Review of clinical features and management

  • Review Article
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Petty RE, Laxer RM. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. editors. Textbook of Pediatric Rheumatology. Philadelphia, PA: Elsiever Saunders; 2005. p. 342–391.

    Chapter  Google Scholar 

  2. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58:556–562.

    Article  PubMed  Google Scholar 

  3. Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456–459.

    Article  PubMed  CAS  Google Scholar 

  4. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adultonset systemic lupus erythematosus. Arthritis Rheum. 2009;61:13–20.

    PubMed  Google Scholar 

  5. Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis. 2009;68:412–415.

    Article  PubMed  CAS  Google Scholar 

  6. Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, et al. Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol. 1999;28:222–226.

    Article  PubMed  CAS  Google Scholar 

  7. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adultand childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995;34:866–872.

    Article  PubMed  CAS  Google Scholar 

  8. Tucker LB, Uribe AG, Fernandez M, Vilá LM, McGwin G, Apte M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17:314–322.

    Article  PubMed  CAS  Google Scholar 

  9. Mina R, Brunner HI. Peadiatric Lupus- are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus. Rheum Dis Clin N Am. 2010;36:53–80.

    Article  Google Scholar 

  10. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 1979;22:328–333.

    Article  PubMed  CAS  Google Scholar 

  11. Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004;22:776–780.

    PubMed  CAS  Google Scholar 

  12. Kurahara DK, Grandinetti A, Fujii LL, Tokuda AA, Galario JA, Han MJ, et al. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol. 2007;34:425–429.

    PubMed  Google Scholar 

  13. Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993;2:115–118.

    Article  PubMed  CAS  Google Scholar 

  14. Samanta A, Roy S, Feehally J, Symmons DP. The prevalence of systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol. 1992;31:679–682.

    Article  PubMed  CAS  Google Scholar 

  15. Mondal R, Nandi M, Ganguli S, Ghosh A, Hazra A. Childhood Lupus: Experience from Eastern India. Indian J Pediatr. 2010 Aug 24. [Epub ahead of print]

  16. Hochberg MC. Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

    Article  PubMed  CAS  Google Scholar 

  17. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodríguez-Mahou M, Bascones M, González CM, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus. 1999;8:287–292.

    Article  PubMed  CAS  Google Scholar 

  18. Pande I, Sekharan NG, Kailash S, Uppal SS, Singh RR, Kumar A, et al. Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus. 1993;2:83–87.

    Article  PubMed  CAS  Google Scholar 

  19. Kumar S, Nair S, Rajam L. Case series of pediatric systemic lupus erythematosus from Kerala: comparison with other Indian series. Int J Rheum Dis. 2010;13:391–395.

    Article  PubMed  Google Scholar 

  20. Zappitelli M, Duffy CM, Bernard C, Gupta IR. Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol. 2008;23:83–91.

    Article  PubMed  Google Scholar 

  21. Cameron JS. Lupus nephritis in childhood and adolescence. Paediatr Nephrol. 1994;8:230–249.

    Article  CAS  Google Scholar 

  22. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241–250.

    Article  PubMed  Google Scholar 

  23. Elliot V, Cairns T, Cook HT. Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. Am J Kidney Dis. 2006;47:184–190.

    Article  PubMed  Google Scholar 

  24. Spronk PE, ter Borg EJ, Kallenberg CG. Patients with systemic lupus erythematosus and Jaccoud’s arthropathy: a clinical subset with an increased C reactive protein response? Ann Rheum Dis. 1992;51:358–361.

    Article  PubMed  CAS  Google Scholar 

  25. Perilloux BC, Shetty AK, Leiva LE, Gedalia A. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study. Clin Rheumatol. 2000;19:200–203.

    Article  PubMed  CAS  Google Scholar 

  26. Cross LS, Aslam A, Misbah SA. Antinuclear antibody negative lupus as a distinct diagnostic entity. Does it no longer exist. QJM. 2004;97:303–308.

    Article  PubMed  CAS  Google Scholar 

  27. Cabral DA, Petty RE, Fung M, Malleson P. Persistent antinuclear antibodies in children without identifiable rheumatic or autoimmune disease. Pediatrics. 1992;89:441–444.

    PubMed  CAS  Google Scholar 

  28. Deane PMG, Liard G, Siegel DM, Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995;95:892–895.

    PubMed  CAS  Google Scholar 

  29. Esdaile JM, Abrahamowicz M, Joseph L, MacKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum. 1996;39:370–378.

    Article  PubMed  CAS  Google Scholar 

  30. Breda L, Nozzi M, De Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin Arthritis Rheum. 2009;40:53–72.

    Article  PubMed  Google Scholar 

  31. Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E. Autoantibodies in paediatric systemic lupus erythematosus: ethnic grouping, cluster analysis and clinical correlation. J Rheumatol. 2009;36:416–421.

    Article  PubMed  Google Scholar 

  32. Leana W, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy and Clin Immunol. 2004;113:585–593.

    Article  Google Scholar 

  33. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009;1173:47–51.

    Article  PubMed  CAS  Google Scholar 

  34. Silverman E, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol. 1991;18:120–124.

    PubMed  CAS  Google Scholar 

  35. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol. 1993;82:11–16.

    PubMed  CAS  Google Scholar 

  36. Buyon JP, Heibert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune associated congetnital-heart block: demographics, mortality, morbidity and recurrence rates obtained from a natonal neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–1666.

    Article  PubMed  CAS  Google Scholar 

  37. Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senécal JL, Cividino A, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus. 1998;7:80–85.

    Article  PubMed  CAS  Google Scholar 

  38. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69:20–28.

    Article  PubMed  CAS  Google Scholar 

  39. Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, et al. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol. 2002;15:123–129.

    PubMed  Google Scholar 

  40. Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr. 2000;136:243–247.

    Article  PubMed  CAS  Google Scholar 

  41. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol. 2001;28:2103–2108.

    PubMed  CAS  Google Scholar 

  42. Fu YF, Liu GL. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine. Clin Nephrol. 2001;55:318–321.

    PubMed  CAS  Google Scholar 

  43. Kazyra I, Pilkington C, Marks SD, Tullus K. Mycophenolate mofetil treatment in children and adolescents with lupus. Arch Dis Child. 2010;95:1059–1061.

    Article  PubMed  Google Scholar 

  44. Baca V, Catalán T, Villasís-Keever M, Ramón G, Morales AM, Rodríguez-Leyva F. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhoodonset lupus nephritis. Lupus. 2006;15:490–495.

    Article  PubMed  CAS  Google Scholar 

  45. Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus 2007;16:896–900.

    Article  PubMed  CAS  Google Scholar 

  46. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, et al. Long-term follow-up of childhood lupus nephritis. J Rheumatol. 2002;29:2635–2642.

    PubMed  Google Scholar 

  47. Lionaki S, Kapitsinou PP, Iniotaki A, Kostakis A, Moutsopoulos HM, Boletis JN. Kidney transplantation in lupus patients: a case-control study from a single centre. Lupus. 2008;17:670–675.

    Article  PubMed  CAS  Google Scholar 

  48. Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005;45:903–911.

    Article  PubMed  Google Scholar 

  49. Baca V, Lavalle C, Garcia R, Catalán T, Sauceda JM, Sánchez G, et al. Favourable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric Lupus. J Rheumatol. 1999;26:432–439.

    PubMed  CAS  Google Scholar 

  50. Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus. 2003;12:741–746.

    Article  PubMed  CAS  Google Scholar 

  51. Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010;62:222–233.

    Article  PubMed  CAS  Google Scholar 

  52. Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, et al. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy. Nephrol Dial Transplant 2011 Mar 8. [Epub ahead of print].

  53. Pottier V, Pierrot M, Subra JF, Mercat A, Kouatchet A, Parrot A, et al. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus. 2011 Feb 18. [Epub ahead of print]

  54. Gonzalez B, Hernandez P, Olguin H, Miranda M, Lira L, Toso M, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years’ experience in Chile. Lupus. 2005;14:918–923.

    Article  PubMed  CAS  Google Scholar 

  55. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119:700–706.

    Article  PubMed  Google Scholar 

  56. Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol. 1983;29:196–210.

    Article  PubMed  CAS  Google Scholar 

  57. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–2557.

    Article  PubMed  CAS  Google Scholar 

  58. Brunner HI, Sherrard TM, Klein-Gitelman MS. Cost of treatment of childhood onset systemic lupus erythematosus. Arthritis Rheum. 2006;55:184–188.

    Article  PubMed  Google Scholar 

  59. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:37–47.

    Article  CAS  Google Scholar 

  60. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514–521.

    Article  PubMed  Google Scholar 

  61. Saar P, Hermann W, Müller-Ladner U. Connective tissue diseases and pregnancy. Rheumatology. 2006;45:Siii30–Siii32.

    Article  Google Scholar 

  62. Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J. 2001;77:157–165.

    Article  PubMed  CAS  Google Scholar 

  63. Silva CA, Hilario MO, Febronio MV, Oliveira SK, Almeida RG, Fonseca AR, et al. Pregnancy outcome in juvenile systemic lupus erythematosus: A Brazilian multicenter cohort study. J Rheumatol. 2008;35:1414–1418.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. V. Ramanan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Habibi, S., Saleem, M.A. & Ramanan, A.V. Juvenile systemic lupus erythematosus: Review of clinical features and management. Indian Pediatr 48, 879–887 (2011). https://doi.org/10.1007/s13312-011-0143-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-011-0143-5

Keywords

Navigation